This inventor holds 4 USPTO granted patents, plus 12 CIPO patents and 1 EPO patent. Top assignees: Chengdu Kanghong Biotechnologies Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Huawei Technologies Co., Limited. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010-2025
Title: Zheng Liu: Innovator in Therapeutics and Technology
Introduction
Zheng Liu is a prominent inventor based in Nanjing, China. He has made significant contributions to the fields of therapeutics and technology, holding a total of 4 patents. His innovative work focuses on improving treatment methods and enhancing user experiences through technology.
Latest Patents
One of Zheng Liu's latest patents is a therapeutic combination of a quinoline derivative and an antibody. This application provides a combination that includes an immune checkpoint inhibitor and a tyrosine kinase inhibitor. The therapeutic combination demonstrates good activity against lung tumors and liver tumors. Another notable patent involves a method and terminal for determining operation objects through a touch screen. This method allows for a more efficient user experience by reducing the need for additional operations when interacting with a transparent virtual keyboard.
Career Highlights
Zheng Liu has worked with notable companies such as Chengdu Kanghong Biotechnologies Co., Ltd. and Huawei Technologies Co., Limited. His experience in these organizations has contributed to his expertise in both biotechnology and technology development.
Collaborations
Zheng Liu has collaborated with talented individuals in his field, including Jianmin Fang and Dechao Yu. These collaborations have likely enriched his work and led to innovative solutions in his projects.
Conclusion
Zheng Liu's contributions to therapeutics and technology highlight his role as an influential inventor. His patents reflect a commitment to advancing medical treatments and enhancing user interactions with technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile